Photo from Erman Akkus/X
Aug 21, 2024, 14:40
Erman Akkus: Our review on platinum chemotherapy for metastatic castration-resistant prostate cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on X:
“Our review on “platinum chemotherapy for metastatic castration-resistant prostate cancer” has been published in Cancer Treatment.
Reviews at ESMO and Yüksel Ürün.
Platinum-based chemotherapy (esp. carboplatin) may be offered after first line treatments, if
-dDDR (esp. BRCA).
-Fit for chemotherapy.
-PARPi not available.”
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12